Kerala Ayurveda Ltd.
|BSE: 530163||Sector: Health care|
|NSE: N.A.||ISIN Code: INE817B01025|
|BSE LIVE 15:40 | 15 Dec||102.25||
|NSE 05:30 | 01 Jan||Stock Is Not Traded.|
|Mkt Cap.(Rs cr)||108|
|Mkt Cap.(Rs cr)||107.98|
Kerala Ayurveda Ltd. (KERALAAYURVEDA) - News Sector
11.51 am | 15 Dec 2017 | Business Standard
Century Plyboards, Lumax Auto Technologies, Relaxo Foodwear, Waterbase and NRB Bearings were among 15 stocks from the S&P BSE Smallcap index hit their...
6.11 pm | 14 Dec 2017 | Business Standard
Torrent Pharma shares ended day's trade at Rs 1,316.3 a share, down 0.72%
4.31 pm | 14 Dec 2017 | Press Trust of India
Received final approval to treat Parkinson's disease and acute uncomplicated urinary tract infections
3.00 pm | 12 Dec 2017 | Business Standard
The stock moved higher by nearly 2% to Rs 852, extending its past three days 3.5% gain on the BSE
9.56 am | 12 Dec 2017 | Business Standard
The stock rallied 6% to Rs 2,328 on BSE after the company announced that it has received EIR from the US drug regulator for its facility in Hyderabad ...
8.26 am | 12 Dec 2017 | Business Standard
Few trading ideas by Vaishali Parekh, Research Analyst - Technical Research at Prabhudas Lilladher
12.55 am | 12 Dec 2017 | Business Standard
Torrent invested Rs 60 cr in its insulin manufacturing facility at Indrad so far, which had been set up in partnership with Novo Nordisk India in 2009
12.00 am | 12 Dec 2017 | Business Standard
Given the India focus, they will benefit more from domestic market growth, compared with Indian companies, which are currently facing pressure in thei...
12.58 pm | 11 Dec 2017 | Business Standard
Max India hit 52-week low of Rs 128, dipped 4.5%, while Fortis Healthcare down 3% at Rs 143 on the NSE
8.24 am | 11 Dec 2017 | Business Standard
Stock calls and outlook on Nifty by Sameet Chavan, Chief Analyst- Technical & Derivatives, Angel Broking:
11.44 pm | 9 Dec 2017 | Press Trust of India
A state government panel probing allegations of overcharging against Gurgaon's Fortis hospital had found 'several irregularities'
8.38 pm | 8 Dec 2017 | Press Trust of India
The regulatory filing to the BSE added that Biocon Biologics India is a step down wholly owned subsidiary of the company
12.57 pm | 7 Dec 2017 | Business Standard
The stock was down 3% to Rs 352, falling 6% from its early morning high of Rs 374 on the BSE.